Health ProductsDear Healthcare Professional Letter

Archived - Recall TAXUS Express Coronary Stent Systems and Express Coronary Stent Systems - Boston Scientific

· Published by Health Canada · Official notice

Details

Alert type: Dear Healthcare Professional Letter
Category: Medical Device
Audience: Healthcare Professionals
Department: Health Canada
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Details

This is duplicated text of a letter from Boston Scientific
Contact the company for a copy of any references, attachments or enclosures.

Notice about Health Canada advisories

Health Canada Endorsed Important Safety Information on TAXUS Express2 Paclitaxel-Eluting Coronary Stent Systems and Express2 Coronary Stent Systems

July 20, 2004

Subject: URGENT RECALL NOTICE - Immediate Action Required TAXUSTM Express2TM Paclitaxel-Eluting Coronary Stent Systems and Express2TM Coronary Stent Systems

Dear Risk Manager,

On July 2, 2004, Boston Scientific initiated a voluntary recall of two lots of TAXUSTM Express2TM Paclitaxel-Eluting Coronary Stent Systems after determining that units from these lots may have an increased likelihood of focal neckdown (narrowing) of the balloon deflation lumen, which could result in an increased possibility of a "no deflation" condition. Upon additional analysis and investigation of "no deflation" complaints, Boston Scientific is extending the scope of this recall to include certain additional lots of the TAXUSTM Express2TM Paclitaxel-Eluting Coronary Stent Systems, as well as specific lots of the Express2TM Coronary Stent Systems. Units from these lots may also have an increased likelihood of focal neckdown of the balloon deflation lumen. This voluntary recall does not impact the safety of stents which have been implanted in patients. Patients with the Express2TM or TAXUSTM Express2TM stents should be reassured that this recall does not implicate the stent itself and their ongoing care is unchanged.

We are sending you this recall notification because our records indicate that your institution received one or more units of TAXUSTM Express2TM Paclitaxel- Eluting Coronary Stent Systems and/or Express2TM Coronary Stent Systems.

A "no deflation" complaint is defined as a reported failure of the delivery balloon to deflate within one minute. "No deflation" can cause significant patient complications including coronary artery bypass graft (CABG) surgery and death. Corrective actions associated with the root cause of the "no deflate" condition have been identified and were implemented after the manufacturing dates of the lots subject to this recall.

The information set forth on Attachment A to this letter describes the lots of TAXUSTM Express2TM Paclitaxel-Eluting Coronary Stent Systems that are subject to this recall. The information set forth on Attachment B to this letter describes the lots of Express2TM Coronary Stent Systems that are subject to this recall. Coronary Stent Systems having lot numbers that are not described on Attachments A or B are not subject to this recall.

PLEASE IMMEDIATELY DISCONTINUE USE OF AND SEGREGATE ALL UNITS FROM THESE RECALLED LOTS.

Please carefully review and follow the enclosed steps for Voluntary Recall and complete and return the enclosed Tracking/Verification Form.

Your local Boston Scientific sales representative can answer questions that you may have regarding this voluntary recall. Any TAXUSTM Express2TM Paclitaxel-Eluting Coronary Stent Systems returned will be exchanged, or at your request a credit will be issued. Any Express2TM Coronary Stent Systems returned will be exchanged, or at your request a credit will be issued.

Health Canada has been notified of this voluntary recall.

Any occurences of serious and /or unexpected adverse reactions should be reported to Boston Scientific Canada or Health Canada at the following addresses:

Boston Scientific Canada
350 Traders Blvd East
Mississauga, Ontario
L4Z 1W7
1-800-832-7822

http://www.bostonscientific.ca/
http://www.bostonscientific.com/

Any suspected adverse incident can also be reported to:
Health Products and Food Branch Inspectorate
HEALTH CANADA
Address Locator: 3002C
Ottawa, Ontario K1A 0K9
Tel: The Medical Devices Hotline 1-800-267-9675

For other inquiries & attachments: please refer to contact information.

The Medical Devices Problem Report Form and Guidelines can be found on the Health Canada web site.

Thank you for your support. We regret any inconvenience that this action may cause, but we appreciate your understanding as we take action to ensure patient safety and customer satisfaction.

Sincerely,

original signed by

Nicole Ouellet, MSc.
Regulatory Compliance Specialist
Boston Scientific Corporation
Tel: 905-501-0350 x3195
Fax: 905-501-0440

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime